Merck Company Stock Analysis

MRK Stock  USD 131.75  6.23  4.96%   
Merck Company is fairly valued with Real Value of 129.85 and Target Price of 117.2. The main objective of Merck stock analysis is to determine its intrinsic value, which is an estimate of what Merck Company is worth, separate from its market price. There are two main types of Merck's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Merck's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Merck's stock to identify patterns and trends that may indicate its future price movements.
The Merck stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Merck is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Merck Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Merck's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merck Company. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Merck Stock Analysis Notes

About 79.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 0.1. Merck Company last dividend was issued on the 14th of March 2024. The entity had 1048:1000 split on the 3rd of June 2021. Merck Co., Inc. operates as a healthcare company worldwide. Merck Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey. Merck operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. It employs 67000 people. To find out more about Merck Company contact Kenneth Frazier at 908 740 4000 or learn more at https://www.merck.com.

Merck Quarterly Total Revenue

14.63 Billion

Merck Company Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Merck's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Merck Company or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Merck Company has a strong financial position based on the latest SEC filings
Over 79.0% of the company shares are owned by institutional investors
Latest headline from ajc.com: Disposition of 6224 shares by Smart Dalton of Merck at 117.89 subject to Rule 16b-3

Merck Company Upcoming and Recent Events

Earnings reports are used by Merck to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Merck previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
25th of April 2024
Upcoming Quarterly Report
View
6th of August 2024
Next Financial Report
View
31st of March 2024
Next Fiscal Quarter End
View
6th of February 2025
Next Fiscal Year End
View
31st of December 2023
Last Quarter Report
View
31st of December 2023
Last Financial Announcement
View

Merck Largest EPS Surprises

Earnings surprises can significantly impact Merck's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2010-05-04
2010-03-310.750.830.0810 
2006-07-24
2006-06-300.650.730.0812 
2014-04-29
2014-03-310.790.880.0911 
View All Earnings Estimates

Merck Thematic Classifications

In addition to having Merck stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Robots And Drones Idea
Robots And Drones
Cross-sector firms and funds that develop or invest in technology that can replicate repetitive human actions
Giant Impact Idea
Giant Impact
Public companies with mega capitalization
Compulsion Idea
Compulsion
Addiction driven consumer products and services

Merck Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Merck is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Merck Company backward and forwards among themselves. Merck's institutional investor refers to the entity that pools money to purchase Merck's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Northern Trust Corp2023-12-31
28.5 M
Jpmorgan Chase & Co2023-12-31
25.4 M
Goldman Sachs Group Inc2023-12-31
24.2 M
Legal & General Group Plc2023-12-31
23.5 M
Deutsche Bank Ag2023-12-31
21.6 M
Bank Of New York Mellon Corp2023-12-31
20.8 M
Amvescap Plc.2023-12-31
16.8 M
Nuveen Asset Management, Llc2023-12-31
16.7 M
Ameriprise Financial Inc2023-12-31
16.4 M
Vanguard Group Inc2023-12-31
244.8 M
Blackrock Inc2023-12-31
201.8 M
Note, although Merck's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Merck Market Capitalization

The company currently falls under 'Mega-Cap' category with a total capitalization of 317.9 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Merck's market, we take the total number of its shares issued and multiply it by Merck's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Merck Profitablity

Merck's profitability indicators refer to fundamental financial ratios that showcase Merck's ability to generate income relative to its revenue or operating costs. If, let's say, Merck is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Merck's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Merck's profitability requires more research than a typical breakdown of Merck's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Net Profit Margin of 0.01 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average.
Last ReportedProjected for 2024
Return On Capital Employed 0.04  0.04 
Return On Assets 0  0 
Return On Equity 0.01  0.01 

Management Efficiency

Merck Company has Return on Asset of 0.0264 % which means that on every $100 spent on assets, it made $0.0264 of profit. This is way below average. Merck's management efficiency ratios could be used to measure how well Merck manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Capital Employed is expected to slide to 0.04. The value of Return On Assets is estimated to slide to 0. At this time, Merck's Non Current Liabilities Total is quite stable compared to the past year. Non Current Liabilities Other is expected to rise to about 10.8 B this year, although the value of Total Current Liabilities will most likely fall to about 13.3 B.
Last ReportedProjected for 2024
Price Book Value Ratio 7.36  6.91 
Enterprise Value Multiple 44.64  46.87 
Price Fair Value 7.36  6.91 
The analysis of Merck's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Merck's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Merck Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Dividend Yield
0.0245
Forward Dividend Yield
0.0245
Forward Dividend Rate
3.08
Beta
0.384

Technical Drivers

As of the 28th of March, Merck secures the Coefficient Of Variation of 334.44, mean deviation of 0.6995, and Risk Adjusted Performance of 0.1712. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Merck Company, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We were able to interpolate data for eighteen technical drivers for Merck, which can be compared to its peers in the industry. Please verify Merck Company information ratio, potential upside, as well as the relationship between the Potential Upside and kurtosis to decide if Merck Company is priced some-what accurately, providing market reflects its recent price of 131.75 per share. Given that Merck Company has treynor ratio of 0.4589, we recommend you to check Merck's last-minute market performance to make sure the company can sustain itself at a future point.

Merck Company Price Movement Analysis

The output start index for this execution was two with a total number of output elements of fifty-nine. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Merck middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Merck Company. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Merck Company Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Merck insiders, such as employees or executives, is commonly permitted as long as it does not rely on Merck's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Merck insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Merck Outstanding Bonds

Merck issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Merck Company uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Merck bonds can be classified according to their maturity, which is the date when Merck Company has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Merck Predictive Daily Indicators

Merck intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Merck stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Merck Corporate Filings

ASR
19th of March 2024
Automatic Shelf Registration Statement under Rule 415 filed with the U.S. Securities and Exchange Commission (SEC)
ViewVerify
F4
11th of March 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
20th of February 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
15th of February 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
14th of February 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
13A
13th of February 2024
An amended filing to the original Schedule 13G
ViewVerify
F4
12th of February 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
8th of February 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify

Merck Forecast Models

Merck's time-series forecasting models are one of many Merck's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Merck's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Merck Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Merck prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Merck shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Merck. By using and applying Merck Stock analysis, traders can create a robust methodology for identifying Merck entry and exit points for their positions.
Last ReportedProjected for 2024
Pretax Profit Margin 0.03  0.03 
Operating Profit Margin 0.05  0.05 
Net Profit Margin 0.01  0.01 
Gross Profit Margin 0.73  0.74 

Current Merck Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Merck analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Merck analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
117.2Strong Buy28Odds
Merck Company current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Merck analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Merck stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Merck Company, talking to its executives and customers, or listening to Merck conference calls.
Merck Analyst Advice Details

Merck Stock Analysis Indicators

Merck Company stock analysis indicators help investors evaluate how Merck stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Merck shares will generate the highest return on investment. By understating and applying Merck stock analysis, traders can identify Merck position entry and exit signals to maximize returns.
Begin Period Cash Flow12.8 B
Long Term Debt33.7 B
Common Stock Shares Outstanding2.5 B
Total Stockholder Equity37.6 B
Tax Provision2.8 B
Quarterly Earnings Growth Y O Y0.453
Property Plant And Equipment Net24.5 B
Cash And Short Term Investments7.2 B
Cash6.9 B
Accounts Payable3.9 B
Net Debt29.4 B
50 Day M A124.0214
Total Current Liabilities25.7 B
Other Operating Expenses56.9 B
Non Current Assets Total74.5 B
Forward Price Earnings14.6413
Non Currrent Assets Other9.2 B
Stock Based Compensation645 M
When determining whether Merck Company is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Merck Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Merck Company Stock. Highlighted below are key reports to facilitate an investment decision about Merck Company Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merck Company. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Complementary Tools for Merck Stock analysis

When running Merck's price analysis, check to measure Merck's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merck is operating at the current time. Most of Merck's value examination focuses on studying past and present price action to predict the probability of Merck's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merck's price. Additionally, you may evaluate how the addition of Merck to your portfolios can decrease your overall portfolio volatility.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Is Merck's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merck. If investors know Merck will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merck listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.453
Dividend Share
2.92
Earnings Share
0.14
Revenue Per Share
23.695
Quarterly Revenue Growth
0.058
The market value of Merck Company is measured differently than its book value, which is the value of Merck that is recorded on the company's balance sheet. Investors also form their own opinion of Merck's value that differs from its market value or its book value, called intrinsic value, which is Merck's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merck's market value can be influenced by many factors that don't directly affect Merck's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Merck's value and its price as these two are different measures arrived at by different means. Investors typically determine if Merck is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merck's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.